Benjamin F. Edwards & Company’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.84M | Buy |
34,081
+33,418
| +5,040% | +$1.8M | 0.03% | 388 |
|
|
2024
Q1 | $45K | Buy |
663
+563
| +563% | +$38.2K | ﹤0.01% | 1328 |
|
|
2023
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 1796 |
|
|
2023
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 1545 |
|
|
2023
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 1494 |
|
|
2023
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 1528 |
|
|
2022
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 1613 |
|
|
2022
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 1458 |
|
|
2022
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 1486 |
|
|
2022
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 1469 |
|
|
2021
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 1424 |
|
|
2021
Q3 | $11K | Hold |
100
| – | – | ﹤0.01% | 1349 |
|
|
2021
Q2 | $16K | Sell |
100
-100
| -50% | -$16K | ﹤0.01% | 1268 |
|
|
2021
Q1 | $24K | Buy |
+200
| New | +$24K | ﹤0.01% | 1158 |
|
|
2019
Q4 | – | Sell |
-400
| Closed | -$16K | – | 1869 |
|
|
2019
Q3 | $16K | Sell |
400
-827
| -67% | -$33.1K | ﹤0.01% | 1254 |
|
|
2019
Q2 | $58K | Hold |
1,227
| – | – | ﹤0.01% | 862 |
|
|
2019
Q1 | $44K | Sell |
1,227
-400
| -25% | -$14.3K | ﹤0.01% | 897 |
|
|
2018
Q4 | $46K | Buy |
1,627
+800
| +97% | +$22.6K | ﹤0.01% | 844 |
|
|
2018
Q3 | $37K | Buy |
827
+350
| +73% | +$15.7K | ﹤0.01% | 941 |
|
|
2018
Q2 | $28K | Buy |
477
+377
| +377% | +$22.1K | ﹤0.01% | 996 |
|
|
2018
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 1392 |
|
|
2017
Q4 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 1445 |
|